Washington, March 4 (IANS) The U.S. International Trade Commission (USITC) has received a complaint alleging that biosimilar versions of the cancer drug pertuzumab imported into the United States violate U.S. trade law. Several entities of India’s largest biopharmaceutical company, Biocon, have been named as respondents.The notice was published in the Federal Register. It said the complaint was filed by the world’s top biotech company, Genentech, on February 27, 2026.“The Commiss…
Latest US International Trade Commission News & Updates
Washington, Jan 22 (IANS) The US International Trade Commission has opened a trade investigation into dental burs and kits imported into the US, with several Pakistani companies named as respondents.The investigation was launched under Section 337 of the Tariff Act of 1930 after a complaint by Huwais IP Holding LLC and Versah LLC, both based in Michigan, according to a notice published in the Federal Register.The complainants allege that imported “osseodensification dental burs and kits thereo…
Washington, Dec 26 (IANS) The US International Trade Commission has taken up a complaint that targets several Pakistan-based dental product exporters, opening the door to possible import bans on their goods in the American market.The Commission said it received the complaint on December 16 from Huwais IP Holding LLC and Versah, LLC. The filing alleges violations of Section 337 of the Tariff Act of 1930 involving the import and sale of “certain dental burs and kits thereof” in the United Stat…
Washington, Dec 26 (IANS) The US Department of Commerce has issued a final affirmative determination that producers and exporters of hard empty capsules from India received countervailable subsidies, a finding that could lead to the imposition of countervailing duties on Indian exports pending a separate injury ruling by the US International Trade Commission (ITC).In a notice published in the Federal Register and applicable from December 29, Department of Commerce said its investigation covered …